Artificial Intelligence in Diagnostics Market – By Component (Software, Services, Hardware), Application (Radiology, Oncology, Cardiology, Neurology, Pathology, Infectious Diseases), End-use (Hospitals & Clinics, Imaging Centers), & Forecast, 2024 – 2032

AI in Diagnostics Market Size

Artificial Intelligence in diagnostics market size was valued at USD 1.1 billion in 2023 and is expected to exhibit growth at a CAGR of 22.2% from 2024 to 2032. The rising market growth can be attributed to increasing prevalence of chronic diseases coupled with growing demand for AI tools in disease diagnosis.
 

The rising prevalence of chronic diseases is a key factor propelling the market growth as healthcare providers increasingly leverage AI solutions to improve early detection, precise diagnosis, and tailored treatment strategies for conditions such as diabetes and cancer among others. The surge in chronic conditions is fueled by various factors including aging population, sedentary lifestyles, and suboptimal dietary habits, which resulted in significant increase in target population and healthcare demand. For instance, the World Health Organization (WHO) reported in 2023 that chronic diseases account for 71% of all deaths globally, with cardiovascular diseases alone responsible for 17.9 million deaths annually.
 

Additionally, the rising demand for AI tools is catalyzing the growth of the AI in diagnostics market, as healthcare facilities increasingly focus on enhanced diagnostic precision, operational efficiency, and superior patient outcomes. This demand is driven by the increasing complexity of medical data, the need for faster and more reliable diagnostic processes, and the growing emphasis on personalized medicine. Furthermore, rapid advancements in AI technologies and the broader adoption of digital healthcare platforms are accelerating the integration of AI tools across diagnostic applications.
 

Artificial intelligence in diagnostics refers to the application of advanced AI technologies to analyze medical data and assist in the diagnosis of diseases and medical conditions. This involves the use of algorithms and models that can process large volumes of patient data, including medical images, lab results, and electronic health records, to identify patterns, predict outcomes, and provide diagnostic insights.
 

Artificial Intelligence in Diagnostics Market Trends

The rapid advancement of cutting-edge AI technologies is fundamentally reshaping the diagnostics landscape, driving significant growth in the market throughout the analysis period.
 

• One of the key development is the evolution of deep learning algorithms that enable more accurate analysis of complex medical images, enhancing the detection of conditions such as cancer and cardiovascular diseases.
   
• Additionally, natural language processing (NLP) is transforming how unstructured medical data, such as doctors' notes and patient records, are analyzed. This allows for more comprehensive diagnostics by extracting valuable insights from a broader range of data sources.
   
• Further, another significant advancement includes the AI-powered predictive analytics, which is revolutionizing early diagnosis by forecasting disease onset based on patient data trends. These tools are particularly beneficial in managing chronic diseases, where early intervention can drastically improve outcomes.
   
• For instance, Tempus, through its different AI related tools, is utilizing AI to predict patient responses to treatments, enabling more personalized care pathways. These advancements underscore the significant role that cutting-edge AI technologies are playing in enhancing diagnostic capabilities, thereby fueling market growth and transforming the future of healthcare diagnostics.
   

Artificial Intelligence in Diagnostics Market Analysis

Based on component, the market is classified into software, services, and hardware. The software segment generated the highest revenue of USD 644.8 million in 2023.
 

• AI diagnostics primarily depends on sophisticated algorithms and machine learning models, which are embedded in software platforms. These platforms analyze complex medical data, such as imaging and genomic information, and provide actionable insights, making software the backbone of AI-driven diagnostics.
   
• Software can be regularly updated and improved with new algorithms, features, and capabilities, allowing healthcare providers to stay at the cutting edge of diagnostic technology. This adaptability and scalability have become a crucial component in the rapid evolution of AI diagnostics.
   

Based on application, the artificial intelligence in diagnostics market is categorized into radiology, oncology, cardiology, neurology, pathology, infectious diseases, and other applications. The radiology segment dominated the market accounting for a revenue share of 28.4% in 2023.
 

• Radiology involves the analysis of large volumes of medical images such as X-rays, CT scans, MRIs, and ultrasounds. AI tools are highly effective in handling and interpreting these images, making radiology a prime area for AI integration. The ability of AI to quickly and accurately analyze images has significantly improved diagnostic efficiency, leading to widespread adoption.
   
• Radiology was one of the first medical fields to incorporate AI, particularly in image recognition and interpretation. The early adoption of AI in radiology has allowed for more mature and refined AI tools, which are now widely trusted and utilized across healthcare facilities, contributing to the segment growth.

Based on end-use, the artificial intelligence in diagnostics market is segmented into hospitals & clinics, diagnostic laboratories, imaging centers, and other end-users. The hospitals & clinics segment dominated the market in 2023 and is anticipated to reach USD 3.3 billion by 2032.
 

• Hospitals and clinics serve a large and diverse patient population, requiring a wide range of diagnostic services. AI-powered diagnostic tools are essential in these settings to manage the high volume of diagnostic procedures, from imaging to laboratory tests, ensuring quick and accurate results.
   
• Hospitals and clinics are often the first to adopt advanced medical technologies, including AI in diagnostics. They have the resources and infrastructure to implement and integrate AI systems across various departments, enhancing diagnostic capabilities and improving patient care.

North America AI in diagnostics market accounted for USD 451.6 million market revenue in 2023 and is anticipated to grow at CAGR of 21.2% between 2024 – 2032 period.
 

• North America, particularly the U.S., is at the forefront of adopting cutting-edge healthcare technologies. The region's healthcare providers are keen on integrating AI-driven diagnostic tools to enhance accuracy, reduce diagnostic errors, and improve patient outcomes. This widespread adoption is fueled by a strong focus on technological innovation and a well-established healthcare infrastructure.
   
• Additionally, the region has a high prevalence of chronic diseases, including cardiovascular diseases, diabetes, and cancer. AI-based diagnostics are crucial in the early detection and management of these conditions, driving demand for AI solutions in the healthcare sector.
   

U.S. artificial intelligence in diagnostics market accounted for USD 412.2 million market revenue in 2023 and is estimated to record healthy growth between 2024 and 2032.
 

• There is a rising demand for personalized medicines in the country, and AI diagnostics play a crucial role in catering to the demand. AI technologies enable more precise and individualized diagnostic outcomes, catering to the growing need for tailored healthcare solutions.
   
• Moreover, the country has a more favorable regulatory environment for the approval and adoption of AI-based diagnostic tools. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) have been increasingly approving AI-driven diagnostic devices, which encourages innovation and accelerates market growth.
   

UK AI in diagnostics market is projected to grow remarkably in the coming years.
 

• The UK government has been actively promoting the adoption of AI technologies through various initiatives and funding programs. These efforts are aimed at enhancing the healthcare system's efficiency and effectiveness, leading to increased investments in the AI-based diagnostic solutions landscape.
   
• Additionally, the country has seen a significant rise in the availability of healthcare data, coupled with advancements in computing power. This combination enables the development of sophisticated AI algorithms that can analyze complex medical data, leading to improved diagnostic accuracy and efficiency. The ability to leverage big data in healthcare is a critical driver for the growth of AI in diagnostics.
   

Japan holds a key position in the Asia Pacific AI in diagnostics market.
 

• Japan's rapidly aging population is a key factor driving the growth and adoption of AI tools in the diagnostics market. As the demand for healthcare services increases, there is a pressing need for efficient diagnostic solutions that can support healthcare professionals in managing chronic diseases and age-related conditions. AI technologies are being adopted to enhance diagnostic capabilities and improve patient outcomes in this context.
   
• Additionally, there is a growing trend of partnerships between technology companies and healthcare providers in Japan. These collaborations aim to integrate AI solutions into existing healthcare systems, facilitating the development of innovative diagnostic tools. Such partnerships are essential for advancing AI applications in medical diagnostics, ensuring that the technology meets the specific needs of the healthcare sector.
   

Artificial Intelligence in Diagnostics Market Share

The market is characterized by the presence of several key players and a focus on technological innovation and strategic partnerships. Companies are investing in AI-driven analytics platforms that provide deeper insights into disease patterns and patient outcomes. Additionally, there is a growing focus on integrating AI with existing infrastructure and the medical imaging capabilities to enable more precise, timely and accurate outcomes. Partnerships between tech firms and healthcare providers are also increasing, driving innovation and expanding the adoption of AI tools and solutions across various healthcare domains.
 

AI in Diagnostics Market Companies

Prominent players operating in the artificial intelligence in diagnostics industry include:

• Aidoc
• AliveCor Inc.
• Digital Diagnostics, Inc.
• Enlitic
• IBM Corporation
• Imagen Technologies
• NVIDIA Corporation
• PathAI
• RADLogics
• Riverain Technologies
• Siemens Healthineers
• Sophia Genetics
• Tempus
• Vuno, Inc.
• Zebra Medical Vision, Inc.
   

Artificial Intelligence in Diagnostics Industry News:

• In June 2024, Aidoc announced the launch of its new AI-powered patient management solution that improves clinic volumes and promotes patient care. This launch is expected to enhance the company’s reputation in the market and enable them to expand their customer base.
   
• In June 2024, AliveCor announced the U.S. Food and Drug Administration (FDA) clearance and commercial launch of its KAI 12L AI technology and the Kardia 12L ECG System. This approval is expected to improve the company’s sales prospect in the coming period.
   

The AI in diagnostics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Component

• Software
• Services
• Hardware

Market, By Application

• Radiology
• Oncology
• Cardiology
• Neurology
• Pathology
• Infectious diseases
• Other applications

Market, By End-use

• Hospitals & clinics
• Diagnostic laboratories
• Imaging centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa